Our Advantages over many hedge firms - Sharp and focus, motivation for success, involve with huge social media influrence.
INO
There lots of of shorts and hedge and with misconceptions the SP drops. Here is a brief recap. INOVIO exit US strategy works! They are multiple countries approached INOVIO for vaccine advice and partnerships for more vaccine options due to COVID, second generation vaccine for booster shots and for countries with low vaccination rate, the future INOVIO pipeline platform. WHO announces large golden trial signed up with multiple countries as a joined venture changing the world’s medicine making a name for INOVIO DNA killer T-cells. Then more countries approved INOVIO phase 3 trial, FDA lifted the banned! Would you give up on your investment now…..Just do not buy stupid calls. Hedge firms are winning as they not only hold shares write out calls, absorbing all calls money buy the cheap shares….do not listen to Cramer just when the right news hit the market things can turn quickly.
The perfect skyrocket INOVIO 2022, after 20 years of hard works in research and development. The Bio-Pharmaceuticals time to start investing into INOVIO, I was telling family and friends. Hedge tactics push the price down for retail investors to load! Without WHO deal we value at 6. But With the deals and what’s going on out there our capital value the company at 12. WHO deals and with the phase 3 development and pipeline should be at 28. If investors consider buying SPAC as an investment, INO definitely fit their portfolio. The abstract was published by Oxford. INO-4800 induced Killer T-Cells react to all variants. Look Tesla was late to the auto industry, but they kept trying and improving finally succeed in the end. So buy the cheap shares and load the 🚤!!! Hold the investment for at least 10 years!!!
GORKAM Investment Group
Stock and Digital Private Equity
We write periodic articles for our capital investment. Research ideas on wall street and share on gorkam.com and on social media for free. We make great impacts on investment on long term investment not for short term.
Investors should make their own judgement calls based on how much risk they can take, everyone's risk tolerance are very different.
FUBO
DWAC
FUBO TV a new streaming platform channels has reported a great qtr 2022 with it's advertisement growth. The company has has a impressive grow on users. Due to the current share price has come down and cool off. We believer now is the time to buy.
INO-4800 DNA vaccine is on top of our list, Room temperature storage proven Safety and Immunogenicity 100%. Clinical results indicate a 100% on efficacy on 38 subjects taking INO-4800 with favorable safety and tolerability profile with no serious adverse events reported. The investment is not a COVID play but a new revolution of DNA medicine that can treat cancer cells and therapeutic medicine to fight virus. INO price around $8, we have BUY rating long term price target $80
Twitter @kambase Published 1/17/2022
SPAC by Trump, a social media platform. This is an interesting play for people who follow Trump. Trump was able to draw millions attention on Twitter platform during his presidency however, the president's account was blocked by Twitter. Trump is opening his own social media platform with supports by Republicans. Some even invested into the company at this early stage.